These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 6095341)
1. Paramagnetic pharmaceuticals for magnetic resonance imaging. Wesbey GE; Engelstad BL; Brasch RC Physiol Chem Phys Med NMR; 1984; 16(2):145-55. PubMed ID: 6095341 [TBL] [Abstract][Full Text] [Related]
2. Nuclear magnetic resonance contrast enhancement study of the gastrointestinal tract of rats and a human volunteer using nontoxic oral iron solutions. Wesbey GE; Brasch RC; Engelstad BL; Moss AA; Crooks LE; Brito AC Radiology; 1983 Oct; 149(1):175-80. PubMed ID: 6611926 [TBL] [Abstract][Full Text] [Related]
4. Paramagnetic contrast agents in magnetic resonance imaging: research at Vanderbilt University. Runge VM; Clanton JA; Price AC; Herzer WA; Wehr CJ; Lukehart CM; Partain CL; James AE Physiol Chem Phys Med NMR; 1984; 16(2):113-22. PubMed ID: 6438656 [TBL] [Abstract][Full Text] [Related]
5. Dual contrast enhanced magnetic resonance imaging of the liver with superparamagnetic iron oxide followed by gadolinium for lesion detection and characterization. Kubaska S; Sahani DV; Saini S; Hahn PF; Halpern E Clin Radiol; 2001 May; 56(5):410-5. PubMed ID: 11384141 [TBL] [Abstract][Full Text] [Related]
6. [Choice of image sequence in contrast medium nuclear magnetic tomography: contrast behavior of brain tumors following gadolinium-DTPA use in various spin-echo procedures]. Schörner W; Semmler W; Felix R; Laniado M; Speck U; Niendorf HP Rontgenpraxis; 1984 Sep; 37(9):323-6. PubMed ID: 6505861 [No Abstract] [Full Text] [Related]
7. First use of GdDTPA/dimeglumine in man. Laniado M; Weinmann HJ; Schörner W; Felix R; Speck U Physiol Chem Phys Med NMR; 1984; 16(2):157-65. PubMed ID: 6505042 [TBL] [Abstract][Full Text] [Related]
8. Differences in metabolic and morphological reactions after radiation therapy: proton NMR spectroscopy and imaging of patients with intracranial tumors. Ikehira H; Miyamoto T; Yasukawa T; Obata T; Katoh H; Koga M; Yoshikawa K; Yoshida K; Tateno Y Radiat Med; 1995; 13(5):199-204. PubMed ID: 8848553 [TBL] [Abstract][Full Text] [Related]
9. [New development of cellulose-ferric ammonium citrate solution as a contrast-enhancement agent for magnetic resonance imaging of esophageal diseases]. Ogawa Y; Noda Y; Sawada A; Fujiwara Y; Hamada N; Terashima M; Inomata T; Yoshida S; Morio K Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Oct; 54(12):1178-80. PubMed ID: 9261198 [TBL] [Abstract][Full Text] [Related]
10. Assessment of kainate toxicity using contrast enhanced magnetic resonance imaging. Beravs K; Frangez R; Demsar F Pflugers Arch; 2000; 440(5 Suppl):R153-4. PubMed ID: 11005651 [TBL] [Abstract][Full Text] [Related]
11. Imaging of inflammation in the peripheral and central nervous system by magnetic resonance imaging. Stoll G; Bendszus M Neuroscience; 2009 Feb; 158(3):1151-60. PubMed ID: 18651996 [TBL] [Abstract][Full Text] [Related]
12. [Gd-DTPA in the diagnosis of brain metastasis]. Kornienko VN; Pronin IN Vestn Rentgenol Radiol; 1994; (5):5-10. PubMed ID: 7785209 [TBL] [Abstract][Full Text] [Related]
13. Spatial diversity of blood-brain barrier alteration and macrophage invasion in experimental autoimmune encephalomyelitis: a comparative MRI study. Ladewig G; Jestaedt L; Misselwitz B; Solymosi L; Toyka K; Bendszus M; Stoll G Exp Neurol; 2009 Nov; 220(1):207-11. PubMed ID: 19733560 [TBL] [Abstract][Full Text] [Related]
14. Lanthanide chelates of (bis)-hydroxymethyl-substituted DTTA with potential application as contrast agents in magnetic resonance imaging. Silvério S; Torres S; Martins AF; Martins JA; André JP; Helm L; Prata MI; Santos AC; Geraldes CF Dalton Trans; 2009 Jun; (24):4656-70. PubMed ID: 19513474 [TBL] [Abstract][Full Text] [Related]
15. Gastrointestinal contrast agents for MR imaging. Brown JJ Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):25-35. PubMed ID: 8673714 [TBL] [Abstract][Full Text] [Related]
16. MR imaging of the breast. Imaging and tissue characterization without intravenous contrast. Santyr GE Magn Reson Imaging Clin N Am; 1994 Nov; 2(4):673-90. PubMed ID: 7489316 [TBL] [Abstract][Full Text] [Related]
17. [Role of gadolinium (Gd-DTPA) in the staging of renal carcinoma using magnetic resonance. Comparative evaluation with computerized tomography and magnetic resonance without contrast media]. De Cobelli F; Vanzulli A; Colombo E; Bonato C; Sironi S; Del Maschio A Radiol Med; 1993 May; 85(5):562-9. PubMed ID: 8327756 [TBL] [Abstract][Full Text] [Related]
18. Cerebral blood volume quantification in a C6 tumor model using gadolinium per (3,6-anhydro) alpha-cyclodextrin as a new magnetic resonance imaging preclinical contrast agent. Lahrech H; Perles-Barbacaru AT; Aous S; Le Bas JF; Debouzy JC; Gadelle A; Fries PH J Cereb Blood Flow Metab; 2008 May; 28(5):1017-29. PubMed ID: 18183033 [TBL] [Abstract][Full Text] [Related]
19. The relationship between partial pressure of oxygen and perfusion in two murine tumors after X-ray irradiation: a combined gadopentetate dimeglumine dynamic magnetic resonance imaging and in vivo electron paramagnetic resonance oximetry study. Goda F; Bacic G; O'Hara JA; Gallez B; Swartz HM; Dunn JF Cancer Res; 1996 Jul; 56(14):3344-9. PubMed ID: 8764132 [TBL] [Abstract][Full Text] [Related]
20. [Biodistribution of new polynitroxides using electron paramagnetic resonance]. Brik ME; Pechine JM; Courtieu J; Lecayon M J Radiol; 1990 Feb; 71(2):125-31. PubMed ID: 2157840 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]